Panlong Pharmaceutical Co., Ltd.

Disclosure and Review Opinions on the List of Incentive Recipients for the 2026 Stock Option Incentive Plan

Announcement on the Addition of Temporary Proposals and Supplementary Notice for the 2025 Annual Shareholders' Meeting

Announcement of Resolutions from the Seventh Meeting of the Fifth Board of Directors

Legal Opinion Letter from Beijing Ruqiang Law Firm on the Draft Stock Option Incentive Plan of Shaanxi Panlong Pharmaceutical Group Co., Ltd. for 2026

Self-Examination Form for Listed Company Equity Incentive Plans

Implementation and Assessment Management Measures for the 2026 Stock Option Incentive Plan

Draft of the 2026 Stock Option Incentive Plan

Summary of the Draft of the 2026 Stock Option Incentive Plan

Legal Opinion from Beijing Ruqiang Law Firm on the First Employee Stock Ownership Plan of Shaanxi Panlong Pharmaceutical Group Co., Ltd.

Review Opinions of the Board of Directors' Compensation and Assessment Committee on Matters Related to the First Employee Stock Ownership Plan and the 2026 Stock Option Incentive Plan

Management Measures for the First Employee Stock Ownership Plan

Summary of the Draft of the First Employee Stock Ownership Plan

Draft of the First Employee Stock Ownership Plan

Announcement on Holding the 2025 Annual Online Performance Briefing

Notice of the 2025 annual general meeting of shareholders.

Announcement of the resolutions of the sixth meeting of the fifth board of directors.

2025 Annual Financial Settlement Report

Announcement on Authorizing the Board to Formulate the Mid-term Dividend Plan

Special Verification Report by Zhongtai Securities Co., Ltd. on the Use of Raised Funds by Shaanxi Panlong Pharmaceutical Group Co., Ltd. for 2025

Announcement on Hiring Accounting Firm for 2026

2025 Annual Independent Director Work Report (Wang Peng)

2025 Annual Independent Director Work Report (Wang Mancang)

2025 Annual Independent Director Work Report (Ren Haiyun)

2025 Annual Independent Director Work Report (Niu Xiaofeng)

2025 Annual Independent Director Work Report (Jiao Leipeng)

Internal Control Audit Report

2025 Annual Internal Control Evaluation Report

Shareholders Meeting Online Voting Management System

Investor Relations Management System

Director and Senior Management Departure Management System